Semaglutide / BPC-157 – (Reconstituted) – 5mg / 650mcg
$150.00
Semaglutide / BPC-157 Blend Reconstituted 5mg / 650 mcg
The Semaglutide / BPC-157 Blend combines the research properties of Semaglutide, a GLP-1 receptor agonist, and BPC-157, a peptide studied for its potential influence on tissue function and cellular signaling. This unique combination is being explored for its potential synergistic effects in metabolic regulation, appetite control, and overall physiological support.
Potential Research Applications
The Semaglutide / BPC-157 blend is currently being studied for its role in:
- Metabolic Function: Investigated for its effects on glucose metabolism and insulin sensitivity.
- Appetite Regulation: Researched for its potential role in satiety and food intake control.
- Tissue Support & Recovery: BPC-157 is examined for its role in cellular function and biological signaling.
- Weight Management: Explored for its combined influence on fat metabolism and energy balance.
✔ High-Quality Research Peptides – Produced under stringent quality control standards.
✔ Lab-Tested for Purity – Ensures consistency for scientific studies.
✔ Research Use Only – Not for human consumption or medical applications.
✔ Peptides – Will arrive in a lyophilized (powder) form for maximum stability and ease of reconstitution.
The peptides are available for research and laboratory purposes only. Please review and ahere to our Terms and Conditions before ordering.
- Description
- Certificate of Analysis
A Semaglutide and BPC-157 blend combines the metabolic benefits of GLP-1 receptor activation with the regenerative properties of BPC. Semaglutide improves glycemic control and appetite regulation, while BPC-157 supports tissue repair and gut health. Together, they create a unique synergy for both metabolic and research applications.
Research indicates that Semaglutide boosts insulin secretion, lowers glucagon levels, and slows gastric emptying, improving glucose control. In contrast, BPC-157 accelerates healing by promoting angiogenesis, reducing inflammation, and protecting the gut lining. This combination may benefit individuals with metabolic disorders who also need enhanced recovery and gut support.
Moreover, Semaglutide’s appetite-suppressing effects, paired with BPC-157’s tissue repair benefits, create a promising strategy for weight management and recovery in research. By improving energy balance and cellular regeneration, this blend can support studies in weight loss or intensive training.
Ongoing research continues to explore the potential of this peptide combination. Early findings suggest that it could extend beyond glucose control and recovery, offering broader benefits in regenerative medicine and chronic disease management.
No Certificate of Analysis images available for this product.
